NON-PVC IV BAGS MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America has been the dominant region in the global non-PVC IV bags market and is estimate to hold a market share of 39.2 % in 2024. This can mainly be attributed to stringent regulations pertaining to the use of plasticizer DEHP in medical devices. In recent years, the U.S. Food and Drug Administration (FDA) has taken a strong stance against the use of DEHP due to potential adverse health effects. As a result, major manufacturers have accelerated their production capabilities of non-PVC alternatives while hospitals and healthcare providers are replacing existing plasticized inventory. Moreover, North America is home to several prominent multinational companies that have established manufacturing facilities and supply chain infrastructure catering to the demands of local hospitals. This helps ensure product and material availability along with supply security.

Over the past five years, the Asia Pacific region has emerged as the fastest growing market for non-PVC IV bags globally. This growth can be linked to rising healthcare expenditures, growing patient volumes, and increasing awareness regarding product safety among medical facilities in developing Asian countries. China, in particular, has built robust local production capacities as it aims to reduce import dependence for medical supplies. Local companies have gained valuable expertise through technical collaborations with international leaders. Additionally, regional trade agreements have strengthened intra-Asia commerce of non-PVC bags. Overall market conditions in the region such as evolving regulations, healthcare reforms, and rising disposable incomes will continue propelling the non-PVC IV bags segment at a rapid pace in Asia Pacific.